Alternatives to Oryon Cell Therapies

Biotechnology company developing and commercializing cell therapies for cancer treatment.

Clinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines.

A life sciences company that has developed a high-throughput platform for mapping molecular cell architecture at nanoscale resolution.

Biopharmaceutical company developing and commercializing CNS disease treatments.

Clinical-stage biotechnology company developing multi-mechanistic oncolytic immunotherapy programs for cancer treatment.

The first Integrated Development and Manufacturing Organization (IDMO) for cell therapies.

A clinical-stage biopharmaceutical company developing novel cell therapies for AL Amyloidosis and other serious diseases.

Advancing clinical stage pipeline targeting new and major neurology and neuropsychiatric disorders.

Developing a novel therapeutic approach for Alzheimer's disease.

Clinical-stage biopharmaceutical company developing transformative, best-in-class neuropsychiatric therapies.

Developing small-molecule modulators of lysosomal ion channels for neurodegenerative diseases.

Accelerating breakthroughs in prostate cancer diagnosis and treatment.

Developing a next-generation, off-the-shelf, in vivo engineered monocyte immunotherapy platform for solid tumors.

Developing and manufacturing laminin-based cell culture substrates for advanced cell therapies and drug discovery.

Empowering Venture Scientists to solve neglected health and planetary challenges through an entrepreneurship-focused doctoral training program.

Biopharmaceutical company developing T-cell therapies for solid tumor cancers.

A commercial-stage immunotherapy company developing novel treatments for cancer and infectious diseases.

Clinical-stage biopharmaceutical company developing treatments for brain and peripheral disorders involving the CB1 receptor.

Enabling sustainable and scalable manufacturing of complex, high-value biomolecules through enzymatic biomanufacturing.

Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.